A quantitative analysis of lymphatic vessels in human breast cancer, based on LYVE-1 immunoreactivity.

A quantitative analysis of lymphatic vessels in human breast cancer, based on LYVE-1 immunoreactivity.

This study was undertaken to determine the highly sensitive method for detecting tumour lymphatic vessels in all the fields of each slide (LV), lymphatic microvessel density (LMVD) and lymphatic vessel invasion (LVI) and to compare them with other prognostic parameters using immunohistochemical stai...

Description complète

Détails bibliographiques
Auteurs principaux:	Kato, T, Prevo, R, Steers, G, Roberts, H, Leek, R, Kimura, T, Kameoka, S, Nishikawa, T, Kobayashi, M, Jackson, D, Harris, A, Gatter, K, Pezzella, F
Format:	Journal article
Langue:	English
Publié:	2005

Documents similaires

LYVE-1, the lymphatic system and tumor lymphangiogenesis.
par: Jackson, D, et autres
Publié: (2001)

Basement membrane protein distribution in LYVE-1-immunoreactive lymphatic vessels of normal tissues and ovarian carcinomas.
par: Vainionpää, N, et autres
Publié: (2007)

Mouse LYVE-1 is an endocytic receptor for hyaluronan in lymphatic endothelium.
par: Prevo, R, et autres
Publié: (2001)

The distribution of lymphatic vessels in lymphomas compared with reactive lymphadenopathy.
par: Pillai, G, et autres
Publié: (2003)

Inflammation-induced uptake and degradation of the lymphatic endothelial hyaluronan receptor LYVE-1.
par: Johnson, L, et autres
Publié: (2007)

Normal lymphatic development and function in mice deficient for the lymphatic hyaluronan receptor LYVE-1.
par: Gale, N, et autres
Publié: (2007)

Prognostic significance of microvessel density and other variables in Japanese and British patients with primary invasive breast cancer.
par: Kato, T, et autres
Publié: (2007)

Lymphatic vessels in vascularized human corneas: immunohistochemical investigation using LYVE-1 and podoplanin.
par: Cursiefen, C, et autres
Publié: (2002)

Biology of the lymphatic marker LYVE-1 and applications in research into lymphatic trafficking and lymphangiogenesis.
par: Jackson, D
Publié: (2004)

High LYVE-1-positive lymphatic vessel numbers are associated with poor outcome in breast cancer.
par: Bono, P, et autres
Publié: (2004)

Novel expression and characterization of lymphatic vessel endothelial hyaluronate receptor (LYVE-1) by ocular surface cells.
par: Chen, L, et autres
Publié: (2004)

The lymphatics revisited: new perspectives from the hyaluronan receptor LYVE-1.
par: Jackson, D
Publié: (2003)

The cortical actin network regulates avidity-dependent binding of hyaluronan by the Lymphatic Vessel Endothelial receptor LYVE-1
par: Stanly, TA, et autres
Publié: (2020)

Lymph and blood vessel architecture in benign and malignant prostatic tissue: lack of lymphangiogenesis in prostate carcinoma assessed with novel lymphatic marker lymphatic vessel endothelial hyaluronan receptor (LYVE-1).
par: Trojan, L, et autres
Publié: (2004)

Lymphatic and blood vessels in parathyroid tumors: Immunohistochemical study with LYVE-1 and von Willebrand factor
par: Tatsuo Tomita
Publié: (2024-08-01)

Binding of hyaluronan to the native lymphatic vessel endothelial receptor LYVE-1 is critically dependent on receptor clustering and hyaluronan organization
par: Lawrance, W, et autres
Publié: (2016)

Hyaluronan in the lymphatics: The key role of the hyaluronan receptor LYVE-1 in leucocyte trafficking
par: Jackson, D
Publié: (2018)

DOES PERITUMORAL LYVE-1 IMMUNOREACTIVITY PREDICT THE SENTINEL LYMPH NODE METASTASIS?
par: Hilal Koçdor, et autres
Publié: (2006-01-01)

High LYVE-1 positive lymphatic vessel numbers are associated with axillary lymph node metastases and poor outcome in breast cancer.
par: Bono, P, et autres
Publié: (2004)

LYVE-1 immunohistochemical assessment of lymphangiogenesis in endometrial and lung cancer.
par: Koukourakis, M, et autres
Publié: (2005)

A mechanism of sialylation functionally silences the hyaluronan receptor LYVE-1 in lymphatic endothelium.
par: Nightingale, T, et autres
Publié: (2009)

The expression of the lymphatic endothelial cell marker LYVE-1 in benign and malignant vascular tumours
par: Edwards, J, et autres
Publié: (2003)

Homodimerisation of the lymph vessel endothelial receptor LYVE-1 through a redox-labile disulfide is critical for hyaluronan binding in lymphatic endothelium
par: Banerji, S, et autres
Publié: (2016)

Homodimerisation of the lymph vessel endothelial receptor LYVE-1 through a redox-labile disulfide is critical for hyaluronan binding in lymphatic endothelium
par: Banerji, S, et autres
Publié: (2016)

Lymphatic vascularisation and involvement of Lyve-1+ macrophages in the human onchocerca nodule.
par: Tarik Attout, et autres
Publié: (2009-12-01)

Distribution of lymphatic vessels in normal and arthritic human synovial tissues.
par: Xu, H, et autres
Publié: (2003)

Distinctive properties of the hyaluronan-binding domain in the lymphatic endothelial receptor Lyve-1 and their implications for receptor function.
par: Banerji, S, et autres
Publié: (2010)

Novel erectile analyses revealed augmentable penile Lyve‐1, the lymphatic marker, expression
par: Kota Fujimoto, et autres
Publié: (2024-01-01)

Absence of lymphangiogenesis and intratumoural lymph vessels in human metastatic breast cancer.
par: Williams, C, et autres
Publié: (2003)

Lymph vessel density in seminomatous testicular cancer assessed with the specific lymphatic endothelium cell markers D2-40 and LYVE-1: correlation with pathologic parameters and clinical outcome.
par: Heinzelbecker, J, et autres
Publié: (2013)

Dendritic cells enter lymph vessels by hyaluronan-mediated docking to the endothelial receptor LYVE-1
par: Johnson, L, et autres
Publié: (2017)

LYVE-1 expression in the endothelium of newly formed vessels of carotid atherosclerotic plaque
par: Anna N. Evdokimenko, et autres
Publié: (2020-09-01)

Mouse lymphatic endothelial cell targeted probes: anti-LYVE-1 antibody-based magnetic nanoparticles
par: Guo Q, et autres
Publié: (2013-06-01)

MT1-MMP sheds LYVE-1 on lymphatic endothelial cells and suppresses VEGF-C production to inhibit lymphangiogenesis
par: Hoi Leong Xavier Wong, et autres
Publié: (2016-03-01)

FK506 induces lung lymphatic endothelial cell senescence and downregulates LYVE-1 expression, with associated decreased hyaluronan uptake
par: Shikshya Shrestha, et autres
Publié: (2020-07-01)

bcl-2 in normal human breast and carcinoma, association with oestrogen receptor-positive, epidermal growth factor receptor-negative tumours and in situ cancer.
par: Leek, R, et autres
Publié: (1994)

LYVE-1 and hyaluronan - a molecular velcro
par: Lawrance, W
Publié: (2013)

VEGF-D promotes the metastatic spread of tumor cells via the lymphatics.
par: Stacker, SA, et autres
Publié: (2001)

Pre-collecting lymphatic vessels form detours following obstruction of lymphatic flow and function as collecting lymphatic vessels.
par: Kimi Asano, et autres
Publié: (2020-01-01)

Deciphering the heterogeneity of the Lyve1+ perivascular macrophages in the mouse brain
par: C. Siret, et autres
Publié: (2022-11-01)